Bock Louis C
SEC-identified person · CIK 1279735 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Zogenix, INC. ZGNX | Director | filed 2010 - 2022 |
| Orexigen Therapeutics, Inc. OREXQ | Director | filed 2007 - 2017 |
| Scorpius Holdings, Inc. SCPX | Director | filed 2013 - 2016 |
| Horizon Therapeutics Public Ltd Co HZNP | Director | filed 2011 - 2011 |
| Diadexus, Inc. vxgn | Director | filed 2010 - 2010 |
| Alimera Sciences INC ALM | Officer | filed 2010 - 2010 |
| Somaxon Pharmaceuticals, Inc. somx | Director | filed 2006 - 2009 |
| SGX Pharmaceuticals, INC. sgxp | Director | filed 2006 - 2008 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.